Press releases
May 16, 2019
Inflammatix Named a Finalist for AACC’s Disruptive Technology Award for Its Rapid HostDx™ Tests
October 4, 2018
Inflammatix to Present New Data at IDWeek 2018 Demonstrating Ability to Perform HostDx™ Fever Test to Rapidly Distinguish Bacterial from Viral Infections Across Multiple Laboratory Platforms
April 10, 2018
Inflammatix Named a Finalist in Fast Company’s 2018 World Changing Ideas Awards for Its Novel HostDx Tests
February 15, 2018
New Study Published in Nature Communications Suggests Sepsis Can Be Detected By Measuring the Immune System
December 19, 2017
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer